+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
QLL QLL

Qualitek Labs Share Price

₹525.00 -18.25 (-3.36%)
103.06% Gain from 52W Low

23 Oct, 2026 4:01 PM (IST)

Qualitek Labs live price: ₹525.00. It opened at ₹550 vs previous close ₹543; intraday high/low: ₹568/₹517. The 50 & 200 DMA stand at ₹528.00/₹441.60.

Qualitek Labs Performance

  • Today's Low
  • ₹517
  • Today's High
  • ₹568
  • 52 Week Low
  • ₹259
  • 52 Week High
  • ₹650
  • Open Price₹550
  • Previous Close₹543
  • Volume8,800
  • 50 DMA₹528.00
  • 100 DMA₹488.20
  • 200 DMA₹441.60

Qualitek Labs Chart

Investment Returns

  • Over 1 Month -15.46%
  • Over 3 Month + 19.32%
  • Over 6 Month + 45.83%
  • Over 1 Year + 17.58%

Smart Investing Starts Here Start SIP with Qualitek Labs for Steady Growth!

Invest Now

Qualitek Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 38.5
  • PEG Ratio
  • -
  • Market Cap Cr
  • 524
  • P/B Ratio
  • 3.5
  • Average True Range
  • 31.6
  • EPS
  • 13.7
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.1
  • RSI
  • 43.74
  • MFI
  • 32.92

Latest Stock News Updates

Qualitek Labs Ltd - 544091 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

Receipt of Work Order by Interstellar Testing Centre Private Limited, a Wholly Owned Subsidiary of Qualitek Labs Limited from BRDC, Govt of Meghalaya

Qualitek Labs Ltd - 544091 - Intimation Of Receipt Of Work Order By Interstellar Testing Centre Private Limited, A Wholly Owned Subsidiary Of Qualitek Labs Limited, From Bio-Resources Development Centre (BRDC), Government Of Meghalaya.

As per the attached information

Qualitek Labs Ltd - 544091 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Qualitek Labs Limited has informed the Exchange the regarding the E-voting results and Scrutinizer report for the Extra-Ordinary General Meeting held on October 16,2026.

Qualitek Labs Financials

Qualitek Labs Technicals

EMA & SMA

Current Price
₹525.00
-18.25 (-3.36%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹552.20
  • 50 Day
  • ₹528.00
  • 100 Day
  • ₹488.20
  • 200 Day
  • ₹441.60

Resistance and Support

536.67 Pivot Speed
  • R3 607.30
  • R2 587.70
  • R1 556.30
  • S1 505.30
  • S2 485.70
  • S3 454.30

Qualitek Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-22 Preferential issue of shares
2026-05-20 Audited Results (Revised)
2025-11-12 Half Yearly Results
2025-09-10 Others Inter-alia, to consider 1.Allotment of 16,72,531 equity shares of Rs.10 each at Rs.310.89 per share on a preferential basis to shareholders of Interstellar Testing Centre Pvt. Ltd. through share swap.
2025-05-29 Audited Results & Preferential issue

Qualitek Labs Shareholding Pattern

56.46%
41.85%
1.54%
0.15%

About Qualitek Labs

Qualitek Labs is engaged in the business of providing Testing, Inspection and Certification services in the fields of Automobiles, Defence, Electronics & Electricals, Pharmaceuticals, Medical Devices, Metals, Minerals, Environment Monitoring, Food, Water View More
  • NSE Symbol
  • QLL
  • BSE Symbol
  • 544091
  • Executive Director,Managing Director,Chief Executive Officer
  • Antaryami Nayak
  • ISIN
  • INE0Q1R01012

Similar Stocks to Qualitek Labs

Qualitek Labs FAQs

Qualitek Labs share price is ₹525 As on 26 October, 2026 | 09:00

The Market Cap of Qualitek Labs is ₹523.9 Cr As on 26 October, 2026 | 09:00

The P/E ratio of Qualitek Labs is 38.5 As on 26 October, 2026 | 09:00

The PB ratio of Qualitek Labs is 3.5 As on 26 October, 2026 | 09:00

The 52 week High & Low of Qualitek Labs is ₹650/₹258.6 respectively As on 26 October, 2026 | 09:00

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23